Regenesis was founded with a simple but meaningful mission: to improve quality of life by developing innovative medical technologies that help relieve pain. Today, we continue that mission by researching, designing, manufacturing and supporting energy-based medical devices that expand access to safe, non-invasive, drug-free pain management solutions for patients and providers.
Reprieve by Regenesis® is FDA-cleared to generate deep heating within body tissues for the treatment of conditions such as relief of pain and muscle spasms, including chronic pain associated with diabetic peripheral neuropathy, osteoarthritis, plantar fasciitis/fasciosis, lumbar pain and musculoskeletal conditions. Designed for at-home use as part of a provider-directed pain management plan, Reprieve provides clinicians with an additional non-invasive treatment option that fits within established clinical workflows.
Chronic pain affects millions of people and represents one of healthcare’s most persistent challenges. Providers are looking for therapies that can be incorporated into comprehensive treatment plans while supporting individualized patient care. Research within the Veterans Health Administration has demonstrated a strong association between chronic pain and suicide risk among military veterans, reinforcing the critical need to identify and treat pain early as part of a comprehensive, whole-person approach to care. With nearly half of all veterans living with chronic pain — and substantially higher rates among women veterans — improving access to effective, drug-free pain management has the potential to meaningfully improve quality of life while supporting broader efforts to address one of the nation’s most significant veteran health challenges. At Regenesis, we work closely with healthcare providers to deliver technology that is practical to implement and easy for patients to use at home, while supporting clinicians through education and resources that help integrate non-invasive treatment options into patient care.
Synergy in the Ecosystem
Greater Phoenix has been an ideal place for our company to grow. The region has developed into a vibrant bioscience ecosystem that brings together research institutions, universities, healthcare systems, entrepreneurs, manufacturers and technology companies. Having these organizations in close proximity creates opportunities for collaboration, accelerates innovation and helps translate new ideas into solutions that can benefit patients.
As a medical device company, we benefit from access to highly skilled engineering, manufacturing, regulatory and business talent. Arizona’s universities continue to produce graduates with expertise in biomedical engineering, life sciences, healthcare and technology, while the region’s business environment supports companies at every stage of growth.
One of the greatest strengths of Greater Phoenix is the collaboration that exists across the bioscience community. Meaningful innovation rarely happens in isolation. Medical device companies, academic researchers, healthcare providers, software developers, manufacturers and service organizations each contribute unique expertise that helps move new ideas from concept to patient care. This collaborative environment encourages knowledge sharing, supports commercialization and strengthens Arizona’s reputation as a center for healthcare innovation.
That collaboration is also an important driver of economic growth. It attracts investment, supports entrepreneurship, creates high-quality jobs and encourages companies to establish and expand operations in Arizona. As more organizations choose Greater Phoenix as their home, the bioscience ecosystem becomes even stronger through expanded partnerships, a growing talent pipeline and continued investment in research and development.
The Now & Future Biosciences Hub
We believe Greater Phoenix is emerging as one of the nation’s leading hubs for biotech and bioscience. Continued investment in research, workforce development, advanced manufacturing and commercialization has positioned the region for long-term success. The commitment demonstrated by industry, healthcare organizations, academic institutions and public partners has created an environment where companies like Regenesis can innovate, grow and contribute to both improved healthcare and a stronger regional economy.
Looking ahead, we see significant opportunity to build on this momentum. Continued support for workforce development, stronger collaboration between industry and academia and partnerships between healthcare providers and innovators will further strengthen Greater Phoenix’s competitive position and accelerate the adoption of technologies that address important clinical needs.
At Regenesis, we are proud to be part of Arizona’s growing bioscience community. We remain focused on our mission of improving quality of life by expanding access to safe, non-invasive, drug-free pain management solutions — and we believe the collaborative spirit and commitment to innovation found in Greater Phoenix will continue to make the region a driving force in the future of healthcare.
Tom Eisiminger Jr., MBA
President & CEO
Regenesis Medical
Read all the bioindustry stories.
